INNOTEST PHOSPHO-TAU(181P) is a solid-phase enzyme immunoassay for the quantitative determination of phosphorylated Tau (Phospho-Tau(181P)) in human cerebrospinal fluid (CSF).

The combined use of CSF-Tau and CSF-β-amyloid(1-42) marker concentrations allows differentiation between Alzheimer’s disease (AD) and normal aging or other neurological diseases such as depression.

The discrimination of AD from non-AD types of dementia such as dementia with Lewy Bodies may be further improved using the quantification of CSF-phospho-Tau(181).

Features & Benefits             

• User-friendly enzyme  immunoassay, standard technology
• Generic and colour-coded components
• Easily automated on microplate processor (generic components)
• Ready-to-use Calibrators reduce inter and intra run variation
• Run Validation Controls for assay run validation
• Sample volume: 75 µL CSF. Duplicate testing is strongly recommended and requires 2 x 75 µL CSF.
• Limit of Detection: 13 pg/mL
  Calibrator range: 15,6 to 1000 pg/mL

For more information, visit Fujirebio.com.